Navigation Links
Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
Date:10/30/2009

iveness measure was the change from baseline to end point of the total mean ADHD Rating Scale IV (ADHD-RS-IV) score. The baseline was defined as the baseline from the previous double-blind study and the end point was defined as the last assessment for which a valid ADHD-RS-IV score was obtained. The ADHD-RS-IV scale contains 18 items and is based on the ADHD diagnostic criteria as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision®, a publication of the American Psychiatric Association.

Daytrana demonstrated significant improvement in the overall mean ( +/-SD) change in ADHD-RS-IV total score from antecedent study baseline to end point of this study of -23.0 ( +/-10.77) P<.001. In addition, the average ADHD-RS-IV mean total scores decreased from this study start to end from 19.8 to 13.8 (P<.001).

Pharmacokinetic Study in Children and Adolescents with ADHD

The pharmacokinetic profile of Daytrana has been previously reported for children aged 6 to 12 years; the data presented today are the first to report Daytrana pharmacokinetics that also included an adolescent population aged 13 to 17 years.

In this one-month, open-label, multiple-phase study, investigators randomized 35 children and 36 adolescents who received either Daytrana (single, multiple fixed, and multiple escalating doses, each worn for nine hours), or OROS MPH. The study's four phases were single dosing, multiple fixed dosing, dose escalation, and follow-up.

Following single and multiple fixed or escalating doses, systemic exposure was greater in children compared with adolescents, and was consistent with their lower body weights. As a result of accumulation, systemic exposure to d-MPH in children after multiple escalating doses was 1.4- to 1.6-fold higher for Daytrana compared with OROS MPH, but in adolescents was similar for the two formulations. '/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Continues to Deliver Excellent Growth From Core Products
2. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
3. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
4. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
5. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
6. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
7. New Hampshire Rx Card Launching Statewide
8. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
9. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
10. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013  B. Braun Medical Inc. (B.Braun) ... safety with products, services and education focused on ... innovative Outlook® 400ES and Space Infusion Systems, and ... the American Association of Critical-Care Nurses (AACN) National ... Boston Convention Center. ...
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- It is no secret that Americans have ... or obese gyms and supplement companies are in line to ... primarily related to dietary issues and a lack of physical ... a glandular problem or even a vitamin deficiency. ... is a lack of vitamin b12 . The vitamin ...
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- Today at American ... Christine Ginocchio discussed Specific Technologies ... rapid identification of microorganisms producing bloodstream infection. Dr. ... of the Division of Infectious Disease Diagnostics at ... not-for-profit, non-sectarian health system. (Photo: ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... Lines for Therapeutic ... Cloning, ... to report, and painstakingly document, the cloning of a,human embryo using donated ... study was published online today by the journal "Stem,Cells.", (Logo: ...
... Cataract surgery involves,removing a clouded natural lens from ... While the operation itself hasn,t changed much over recent,years, ... newer lenses,is their ability to reduce the need for ... Medical School., The Aging Eye: Preventing and Treating ...
Cached Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery 2
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... Board of Directors. Hal B. Jenson, M.D., M.B.A, ... Medicine, has been named President. Maria C. Savoia, ... California San Diego, is the President-Designate, and Glenn A. ... Center, is the Secretary-Treasurer. Kenneth B. Simons, M.D., ...
(Date:5/21/2013)... NJ (PRWEB) May 21, 2013 Dr. ... Adult) and Director of the Sarcoma Division of the ... in New Jersey has been named one of the ... Orthopedics This Week. Dr. Wittig is one of ... Oncology. The list was created by surveying thought leaders ...
(Date:5/21/2013)... 21, 2013 Brunswick Laboratories, Inc. ... the development and standardization of validated analytical methods, ... Brunswick Laboratories and the USDA, as a First ... This decision comes after extensive review by an ... Harnly of the U.S. Department of Agriculture. , ...
(Date:5/21/2013)... the Center for Disease Control and Prevention (CDC), there are ... of these bites require medical attention, half of these bites ... the danger that dog bites pose to their children because ... more serious injuries than an adult. For example, the ... and 9 are at the greatest risk of a dog ...
(Date:5/20/2013)... USA Book News announced Monday that ... Performance" won the top honor in its 2013 International ... a multitude of international titles published from 2011-2013, "The ... from both mainstream and new age audiences looking to ... spiritually. , “The Infinity Zone” is a ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3
... The Obesity Action,Coalition (OAC) is calling on the state ... (HB 282) that discriminates,against those affected by obesity by ... feels that HB 282 is outright discrimination,against the obese ... to address the obesity epidemic., Introduced in late ...
... Association (APHA) today released its annual congressional record,which measures ... to public health., APHA,s report was compiled by ... votes during the first session of the 110th,Congress in ... senators voted in support of APHA,s,position on all eight ...
... (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth ... which demonstrated that ENBREL reduced C-reactive protein (CRP), a ... plaque psoriasis following 12 weeks of treatment. Median ... the ENBREL treated group compared to the placebo treated ...
... River Expansion ... Despite CP,s Declared Uncertainty, ROCHESTER, Minn., Feb. 1 ... require mitigation for,the city of Rochester as a condition of ... Railroad (DM&E). The,proposed merger currently ignores the significant environmental impacts,created ...
... Clinton,Campaign today announced the endorsement of the American ... the nation,s 2.9 million,registered nurses., "Too many ... and this,country deserves a president that will make ... M. Patton, MSN, RN, CNOR. "Senator,Clinton has shown ...
... screenings offered to encourage healthy hearts, GLEN BURNIE, ... Baltimore Washington Medical Center has the key,to a healthier ... The medical center will host the fourth annual Day ... 10 a.m. to 3 p.m. at the Severna Park,Community ...
Cached Medicine News:Health News:Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity 2Health News:APHA Scores Members of Congress on Public Health Voting Record 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 2Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 3Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 4Health News:New findings show Enbrel significantly reduced levels of C-reactive protein 5Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 2Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 3Health News:Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger 4Health News:The American Nurses Association Endorses Senator Hillary Rodham Clinton (D-NY) 2Health News:Baltimore Washington Medical Center Hosts Day of Dance for Health 2
... electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes ... design allows for a very close positioning ... a low voltage power source such as ... in volts/cm. The result is exceptionally rapid ...
The HEP-1 system accommodates mini to full size gels with a transfer area of 20cmWx 20cmL, designed specifically for the transfer from polyacrylamide or agarose gels....
... from agarose gels to hybridization membranes in ... and efficiency of transfer by allowing high ... of an integrated system allowing electrophoresis, gel ... hours, versus 29 hours required for conventional ...
Trans-Blot Plus Gel/Cassette Assembly Tray...
Medicine Products: